期刊文献+

7种临床用口服益生菌制剂的活菌数量测定与分析 被引量:2

Determination and Analysis of the Number of Microorganisms in Seven Probiotic Products
下载PDF
导出
摘要 目的比较7种临床用口服益生菌产品的活菌数量与产品标签是否一致。方法用平皿菌落计数法检测产品的活菌数量。结果考察的7种产品共7批的活菌数含量有2个产品的活菌数量与标签不符。结论考察的7种产品中,5种产品的活菌数量与标签标注基本一致。 OBJECTIVE To compare whether the microbial content in 7 probiotic products licensed for medicinal purposes are in line with those stated on the labels. METHODS Viable count of probiotic products was performed by selective plating count method. RESULTS Regarding viable count, two of the total 7 products was lower than that stated on the label. CONCLUSION For the 7 products, 5 of their viable counts are the same noted between the products and that stated on the labels.
作者 姚迪翡 徐翔
出处 《中国现代应用药学》 CAS CSCD 北大核心 2007年第4期342-344,共3页 Chinese Journal of Modern Applied Pharmacy
关键词 益生菌制剂 标签 活菌数 probiotics label viable count
  • 相关文献

参考文献2

二级参考文献93

  • 1[1]Sartor RB.Review article:Role of the enteric microflora in the pathogenesis of intestinal inflammation and arthritis.Aliment Pharmacol Ther 1997; 11 Suppl 3:17-22; discussion 22-23
  • 2[2]vRutgeerts P,Goboes K,Peeters M,Hiele M,Penninckx F,Aerts R,Kerremans R,Vantrappen G.Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum.Lancet 1991; 338:771-774
  • 3[3]D'Haens GR,Geboes K,Peeters M,Baert F,Penninckx F,Rutgeerts P.Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum.Gastroenterology 1998; 114:262-267
  • 4[4]Guarner F,Casellas F,Borruel N,Antolin M,Videla S,Vilaseca J,Malagelada JR.Role of microecology in chronic inflammatory bowel diseases.EurJ Clin Nutr 2002; 56 Suppl 4:S34-S38
  • 5[5]Neut C,Bulois P,Desreumaux P,Membre JM,Lederman E,Gambiez L,Cortot A,Quandalle P,van Kruiningen H,Colombel JF.Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease.Am J Gastroenterol 2002; 97:939-946
  • 6[6]Sartor RB.Targeting enteric bacteria in treatment of inflammatory bowel diseases:why,how,and when.Curr Opin Gastroenterol 2003; 19:358-65
  • 7[7]Duchmann R,Kaiser I,Hermann E,Mayet W,Ewe K,Meyer zum Buschenfelde KH.Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD) Clin Exp Immunol 1995; 102:448-455
  • 8[8]Duchmann R,May E,Heike M,Knolle P,Neurath M,Meyer zum Buschenfelde KH.T cell specificity and cross reactivity towards enterobacteria,bacteroides,bifidobacterium,and antigens from resident intestinal flora in humans.Gut 1999; 44:812-818
  • 9[9]Rath HC,Schultz M,Freitag R,Dieleman LA,Li F,Linde HJ,Scholmerich J,Sartor RB.Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice.Infect Immun 2001; 69:2277-2285
  • 10[10]Madsen KL,Doyle JS,Tavernini MM,Jewell LD,Rennie RP,Fedorak RN.Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice.Gastroenterology 2000; 118:1094-1055

共引文献35

同被引文献18

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部